Losartas 25mg Tablets Малайзія - англійська - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

losartas 25mg tablets

jetpharma sdn. bhd. - losartan potassium -

Losartas 50mg Tablets Малайзія - англійська - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

losartas 50mg tablets

jetpharma sdn. bhd. - losartan potassium -

Losartas 100mg Tablets Малайзія - англійська - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

losartas 100mg tablets

jetpharma sdn. bhd. - losartan potassium -

Intasrisdone-3mg Tablets Малайзія - англійська - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

intasrisdone-3mg tablets

jetpharma sdn. bhd. - risperidone -

Intasrisdone-4mg Tablets Малайзія - англійська - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

intasrisdone-4mg tablets

jetpharma sdn. bhd. - risperidone -

MIDAZ Injection 1mgmL Малайзія - англійська - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

midaz injection 1mgml

jetpharma sdn. bhd. - midazolam -

MIDAZ Injection 5mgmL Малайзія - англійська - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

midaz injection 5mgml

jetpharma sdn. bhd. - midazolam -

Eciliv Tablet Малайзія - англійська - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

eciliv tablet

jetpharma sdn. bhd. - eclipta alba; wedelia calendulacea; phyllanthus niruri; tribulus terrestris; glycyrrhiza glabra -

Opsumit Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

opsumit

janssen-cilag (new zealand) ltd - macitentan 10mg;  ;   - film coated tablet - 10 mg - active: macitentan 10mg     excipient: lactose monohydrate magnesium stearate microcrystalline cellulose opadry white oy-b-28920 amb polysorbate 80 povidone sodium starch glycolate - opsumit, as monotherapy or in combination, is indicated for the long-term treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii, iii, or iv. efficacy has been shown in a pah population including idiopathic and heritable pah, pah associated with connective tissue disorders, and pah associated with corrected simple congenital heart disease.